.jpg "Clifford Robinson, MD photo")
Professor
Washington University in St Louis
Dr. Robinson is a Professor of Radiation Oncology and Cardiology at Washington University in St. Louis. He holds several leadership roles, including Associate Director of Clinical Programs, Medical Director of Radiation Oncology Clinical Research, Chief of the Cardiothoracic and Stereotactic Body Radiotherapy services, and Co-Director of the Center for Noninvasive Cardiac Radiotherapy. Dr. Robinson has established research interests developing and standardizing advanced radiotherapy technologies and novel drug combinations, promoting and codifying multi-disciplinary care and patient-centered decision making, and developing and testing new indications for radiotherapy. He is a Principal investigator for the international randomized PACIFIC-4 trial examining SBRT with or without immunotherapy for early stage lung cancer, a multi-center NIH R01 funded trial examining patient-centered decision making for early stage lung cancer, and an NIH U54 center grant exploring tumor microenvironment effects after radiotherapy. He is also a key developer of the recently opened pivotal randomized Varian sponsored RADIATE-VT trial comparing cardiac radioablation to repeat catheter ablation for patients with high risk refractory ventricular tachycardia.
